
Sumitomo Chemical (SUMICHEM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
10.6B
Gross Profit
4.0B
38.07%
Operating Income
2.0B
19.25%
Net Income
1.8B
16.85%
EPS (Diluted)
₹3.57
Balance Sheet Metrics
Total Assets
39.6B
Total Liabilities
10.6B
Shareholders Equity
29.1B
Debt to Equity
0.36
Cash Flow Metrics
Revenue & Profitability Trend
Sumitomo Chemical Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 31.2B | 28.2B | 34.7B | 30.4B | 26.2B |
Cost of Goods Sold | 18.8B | 18.0B | 22.9B | 19.2B | 16.7B |
Gross Profit | 12.4B | 10.2B | 11.9B | 11.1B | 9.5B |
Gross Margin % | 39.6% | 36.2% | 34.2% | 36.6% | 36.4% |
Operating Expenses | |||||
Research & Development | 15.8M | 13.4M | 11.2M | 12.0M | 7.8M |
Selling, General & Administrative | 1.5B | 1.2B | 1.4B | 1.5B | 1.3B |
Other Operating Expenses | 1.6B | 1.5B | 1.6B | 1.5B | 1.3B |
Total Operating Expenses | 3.2B | 2.8B | 3.1B | 3.0B | 2.6B |
Operating Income | 5.7B | 4.3B | 6.2B | 5.6B | 4.4B |
Operating Margin % | 18.2% | 15.2% | 17.7% | 18.5% | 17.0% |
Non-Operating Items | |||||
Interest Income | 822.8M | 590.0M | 249.4M | 103.5M | 99.5M |
Interest Expense | 47.0M | 35.9M | 38.5M | 47.2M | 41.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 6.8B | 5.0B | 6.5B | 5.8B | 4.5B |
Income Tax | 1.7B | 1.3B | 1.5B | 1.5B | 1.1B |
Effective Tax Rate % | 25.5% | 26.5% | 23.2% | 26.4% | 23.8% |
Net Income | 5.1B | 3.7B | 5.0B | 4.2B | 3.5B |
Net Margin % | 16.2% | 13.1% | 14.5% | 14.0% | 13.2% |
Key Metrics | |||||
EBITDA | 7.2B | 5.5B | 6.9B | 6.1B | 5.0B |
EPS (Basic) | ₹10.13 | ₹7.40 | ₹10.06 | ₹8.49 | ₹6.92 |
EPS (Diluted) | ₹10.13 | ₹7.40 | ₹10.06 | ₹8.49 | ₹6.92 |
Basic Shares Outstanding | 499145736 | 499145736 | 499145736 | 499145736 | 499145736 |
Diluted Shares Outstanding | 499145736 | 499145736 | 499145736 | 499145736 | 499145736 |
Income Statement Trend
Sumitomo Chemical Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 382.3M | 466.4M | 468.9M | 572.5M | 1.9B |
Short-term Investments | 12.2B | 8.4B | 2.6B | 5.2B | 3.4B |
Accounts Receivable | 7.8B | 7.2B | 9.5B | 8.4B | 8.5B |
Inventory | 7.0B | 6.1B | 8.9B | 9.4B | 7.5B |
Other Current Assets | 1.2B | 998.0M | 1.3B | 10.0K | 280.0K |
Total Current Assets | 30.2B | 26.7B | 27.9B | 25.2B | 23.0B |
Non-Current Assets | |||||
Property, Plant & Equipment | 258.9M | 250.3M | 171.4M | 134.1M | 126.9M |
Goodwill | 1.5B | 1.5B | 215.5M | 184.6M | 105.7M |
Intangible Assets | 257.8M | 247.7M | 215.5M | 184.6M | 105.7M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 56.8M | 28.4M | 250.0K | -110.0K | 175.7M |
Total Non-Current Assets | 9.4B | 6.4B | 5.8B | 4.9B | 3.7B |
Total Assets | 39.6B | 33.1B | 33.7B | 30.1B | 26.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 4.9B | 4.3B | 4.9B | 5.2B | 5.9B |
Short-term Debt | 191.1M | 117.4M | 162.3M | 128.6M | 173.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 647.4M | 531.8M | 512.2M | 797.6M | 1.1B |
Total Current Liabilities | 9.7B | 8.0B | 9.3B | 10.2B | 10.8B |
Non-Current Liabilities | |||||
Long-term Debt | 327.8M | 185.1M | 177.4M | 247.2M | 153.3M |
Deferred Tax Liabilities | 265.7M | 236.3M | 136.3M | 139.1M | 50.4M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 941.7M | 680.2M | 539.3M | 609.7M | 495.8M |
Total Liabilities | 10.6B | 8.7B | 9.9B | 10.8B | 11.3B |
Equity | |||||
Common Stock | 5.0B | 5.0B | 5.0B | 5.0B | 5.0B |
Retained Earnings | 3.6B | 2.2B | 1.6B | 1.6B | 1.5B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 29.1B | 24.4B | 23.8B | 19.3B | 15.4B |
Key Metrics | |||||
Total Debt | 518.9M | 302.5M | 339.7M | 375.8M | 326.4M |
Working Capital | 20.6B | 18.7B | 18.5B | 15.0B | 12.2B |
Balance Sheet Composition
Sumitomo Chemical Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 6.8B | 5.0B | 6.5B | 5.8B | 4.5B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -837.0M | 4.5B | -1.1B | -1.5B | -845.8M |
Operating Cash Flow | 5.2B | 9.0B | 5.2B | 3.9B | 3.6B |
Investing Activities | |||||
Capital Expenditures | -285.9M | -619.0M | -1.2B | -1.1B | -428.2M |
Acquisitions | 0 | -578.5M | 0 | - | - |
Investment Purchases | -18.9B | -19.4B | -15.5B | -7.8B | -6.4B |
Investment Sales | 14.6B | 15.9B | 13.3B | 6.0B | 4.0B |
Investing Cash Flow | -4.6B | -4.7B | -3.4B | -3.0B | -2.9B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -440.3M | -3.1B | -499.4M | -400.2M | -275.2M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | -5.1M | -53.5M | 0 | - | 0 |
Financing Cash Flow | -450.4M | -3.2B | -499.4M | -400.2M | -275.2M |
Free Cash Flow | 4.2B | 6.9B | 2.7B | 1.1B | 3.8B |
Net Change in Cash | 173.2M | 1.1B | 1.3B | 551.3M | 442.0M |
Cash Flow Trend
Sumitomo Chemical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
52.19
Forward P/E
40.03
Price to Book
10.00
Price to Sales
8.62
PEG Ratio
1.41
Profitability Ratios
Profit Margin
16.55%
Operating Margin
19.25%
Return on Equity
17.40%
Return on Assets
12.75%
Financial Health
Current Ratio
3.13
Debt to Equity
1.79
Beta
0.05
Per Share Data
EPS (TTM)
₹11.14
Book Value per Share
₹58.12
Revenue per Share
₹67.42
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
sumichem | 290.2B | 52.19 | 10.00 | 17.40% | 16.55% | 1.79 |
Coromandel | 712.9B | 31.54 | 6.42 | 18.41% | 8.56% | 6.95 |
UPL | 622.8B | 3.00 | 1.63 | 2.01% | 0.09% | 105.06 |
PI Industries | 586.6B | 35.37 | 5.78 | 17.58% | 20.81% | 1.81 |
UPL | 565.8B | 50.76 | 1.99 | 2.01% | 2.55% | 66.35 |
Bayer CropScience | 247.6B | 41.72 | 8.69 | 19.93% | 10.29% | 3.69 |
Financial data is updated regularly. All figures are in the company's reporting currency.